E-Therapeutics

Based on advances in chemical biology and network science, network pharmacology is a distinctive new approach to drug discovery. It involves application of network analysis to determine the set of proteins most critical in any disease, and then chemical biology to identify molecules capable of targeting that set of proteins. By addressing the true complexity of disease and by seeking to harness the ability of drugs to influence many different proteins, network pharmacology differs from conventional drug discovery approaches, which have generally been based on highly specific targeting of a single protein. Network pharmacology has the potential to provide new treatments for complex diseases where conventional approaches have failed to deliver satisfactory therapies.

Type
Public
HQ
Long Hanborough, GB
Founded
2003
Size (employees)
27 (est)
E-Therapeutics was founded in 2003 and is headquartered in Long Hanborough, GB

E-Therapeutics Office Locations

E-Therapeutics has an office in Long Hanborough
Long Hanborough, GB (HQ)
Blenheim Office Park, 17 Fenlock Rd

E-Therapeutics Financials and Metrics

E-Therapeutics Financials

E-Therapeutics's revenue was reported to be £67 k in FY, 2009 which is a 5% increase from the previous period.
GBP

Net income (FY, 2017)

(13.1 m)

EBITDA (FY, 2017)

(16.3 m)

EBIT (FY, 2017)

(16.3 m)

Market capitalization (20-Oct-2017)

28.5 m

Closing share price (20-Oct-2017)

0.1

Cash (31-Jan-2017)

14 m
E-Therapeutics's current market capitalization is £28.5 m.
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2015FY, 2016FY, 2016FY, 2017

Revenue

64 k67 k

Cost of goods sold

24 k5 k

Gross profit

40 k62 k

Gross profit Margin, %

63%93%
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(2 m)(1.5 m)(1.8 m)(2.3 m)(3.2 m)(4.2 m)(5 m)(7.8 m)(8.8 m)(13.1 m)

Cash From Operating Activities

(2.2 m)(1.5 m)(1.7 m)(1.9 m)(3.2 m)(4.2 m)(5.7 m)(9.9 m)(9.2 m)(9.4 m)

Cash From Financing Activities

4.1 m4.4 m82 k16.4 m15 k39 m77 k12 k13 k

Net Change in Cash

1.8 m(1.6 m)2.5 m(2 m)5.2 m(1.9 m)2.7 m(5.1 m)4.5 m(1.9 m)
    Y, 2017

    Financial Leverage

    1.1 x
    Show all financial metrics

    E-Therapeutics Operating Metrics

    E-Therapeutics's Projects Launched was reported to be 12 in FY, 2016, which is a 100% increase from the previous period
    FY, 2015FY, 2016

    Projects Launched

    612
    Show all operating metrics

    E-Therapeutics Market Value History

    Traffic Overview of E-Therapeutics

    E-Therapeutics Company Life and Culture

    You may also be interested in